Company intelligence / Profile preview

ESEV Research Development

Rehovot, Israel

Ownership: Private
Employees: ~20
Development stage: Other

Overview

ESEV Research Development is an Israeli biotechnology company specializing in the development of precision cannabinoid-based therapies. The company leverages a proprietary R&D platform to identify and optimize specific combinations of phytocannabinoids and terpenes tailored for distinct medical indications. Their primary focus lies in treating inflammatory and autoimmune conditions, with a pipeline including treatments for psoriasis, Crohn's disease, and atopic dermatitis. By applying pharmaceutical standards to cannabis research, ESEV aims to deliver clinically proven, standardized botanical drug products.

Therapeutic areas: Women's HealthDermatologyGastroenterology
Modalities: Small moleculePhytocannabinoidsTerpenes
Industry: Biotech

Partnerships

Tikun Olam

Beyond the preview

Go deeper on ESEV Research Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESEV Research Development.

Explore the full profile